Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910726 · ClinicalTrials.gov registry record · Phase 2
A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT02910726: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02910726 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02910726, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is being done in patients that have tumors to find out how well sentinel lymph nodes (SLNs) can be found with a special dye called indocyanine green (ICG).
Interventions
- PROCEDURE Sentinel Lymph Node Biopsy
- DRUG indocyanine green (ICG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-09-13 |
| Est. Completion | 2022-09-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02910726
The ClinicalTrials.gov registry entry for NCT02910726 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sentinel Lymph Node Biopsy is the first listed.
NCT02910726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02910726 about?
NCT02910726 is a clinical study titled "A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers". This study is being done in patients that have tumors to find out how well sentinel lymph nodes (SLNs) can be found with a special dye called indocyanine green (ICG).
What is the current status of trial NCT02910726?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2016-09-13. Estimated completion is 2022-09-02.
What interventions are being tested in trial NCT02910726?
The interventions under investigation include: Sentinel Lymph Node Biopsy (PROCEDURE), indocyanine green (ICG) (DRUG).
Who is sponsoring clinical trial NCT02910726?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.